Oliver Schon

Oliver Schon is currently working as the VP, Head of Research & Development at BiVictriX Therapeutics plc. Prior to this, Oliver held various roles at Agenus, including Director - Head of Protein Sciences & Manufacturing at Agenus. Before Agenus, Oliver worked at GSK in various scientific management roles related to Cell Therapy and Transgene Discovery. Oliver has a strong background in biophysics and molecular biology, holding a Ph.D. in Biophysics and Cancer Research from the University of Cambridge. Oliver's expertise lies in developing biologics and novel antibody formats to advance therapeutic candidates for patient benefits.